Busan, South Korea

Youngmin Lee

This inventor holds 1 USPTO granted patent. Top assignee: Konkuk University. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Youngmin Lee. Retrieved from https://idiyas.com/inventor/youngmin-lee-9d1nd3ch

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 14.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Youngmin Lee: Innovator in Immune System Modulation

Introduction

Youngmin Lee is a prominent inventor based in Busan, South Korea. He has made significant contributions to the field of immunology, particularly in the modulation of the immune system. His innovative work has the potential to impact the treatment of diabetic patients.

Latest Patents

Youngmin Lee holds a patent for the "Use of proinsulin for immune system modulation." This patent describes a composition aimed at promoting immune activity, which includes proteins such as dimeric proinsulin and C-peptide partially deleted mutants. The invention also outlines a composition for immunosuppression that utilizes the C-peptide site of proinsulin. This research highlights the application of these components as immune enhancers for diabetic patients. He has 1 patent to his name.

Career Highlights

Youngmin Lee is affiliated with Konkuk University Industrial Cooperation Corporation, where he continues to advance his research and innovations. His work is characterized by a commitment to improving health outcomes through scientific discovery.

Collaborations

He collaborates with notable colleagues, including Soohyun Kim and Si-Young Lee, who contribute to his research endeavors.

Conclusion

Youngmin Lee's innovative work in immune system modulation showcases his dedication to advancing medical science. His contributions have the potential to significantly benefit diabetic patients and enhance immune responses.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…